Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Charalampos Filippatos
Observed name:
C. Filippatos
Institutions:
National and Kapodistrian University of Athens,
Alexandra Hospital
Observed institutions:
National and Kapodistrian University of Athens,
Alexandra Hospital
ORCID:
0009-0005-8971-269X
Observed ORCID:
0009-0005-8971-269X
OpenAlex ID:
A5043221004
Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
2023
·
Charalampos Filippatos
, Ioannis Ntanasis-Stathopoulos
, et al.
·
Viruses
·
34
PDF
Evaluating Minimal Residual Disease Negativity as a Surrogate Endpoint for Treatment Efficacy in Multiple Myeloma: A Meta‐Analysis of Randomized Controlled Trials
2025
·
Ioannis Ntanasis‐Stathopoulos
, Charalampos Filippatos
, et al.
·
American Journal of Hematology
·
32
PDF
Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from Clinical Trials
2025
·
Sabrina Bakogeorgou
, Charalampos Filippatos
, et al.
·
Cancers
·
16
PDF
Observation or treatment for smoldering multiple myeloma? A systematic review and meta-analysis of randomized controlled studies
2025
·
Ioannis Ntanasis-Stathopoulos
, Charalampos Filippatos
, et al.
·
Blood Cancer Journal
·
15
PDF
Chimeric Antigen Receptor T‐Cells ( CAR T‐Cells) in Hematological Malignancies: A Systematic Review and Meta‐Analysis of Proportions From Clinical Trials
2026
·
Charalampos Filippatos
, Ioanna Kanteli
, et al.
·
American Journal of Hematology
·
11
PDF
GLP‐1 receptor agonists in patients with MGUS: A real‐world propensity‐matched study
2025
·
Anastasios Tentolouris
, Ioannis Ntanasis‐Stathopoulos
, et al.
·
European Journal of Clinical Investigation
·
8
PDF
The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
2025
·
Ioannis Ntanasis-Stathopoulos
, Charalampos Filippatos
, et al.
·
Leukemia
·
8
Upfront Anti-CD38 Monoclonal Antibody-Based Quadruplet Therapy for Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials
2025
·
Ioannis Ntanasis-Stathopoulos
, Charalampos Filippatos
, et al.
·
Cancers
·
7
PDF
Prognostic Significance of Endocrine-Related Adverse Events in Patients with Melanoma, Non-Small Cell Lung Cancer and Urothelial Cancer After Treatment with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
2025
·
Stylianos Kopanos
, Charalampos Filippatos
, et al.
·
Cancers
·
6
PDF
Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era
2023
·
Ioannis Ntanasis-Stathopoulos
, Charalampos Filippatos
, et al.
·
Diseases
·
6
PDF
Second Primary Malignancies and Disease Transformation in Patients With Symptomatic Waldenström’s Macroglobulinemia
2025
·
Maria Gavriatopoulou
, Ioannis Ntanasis-Stathopoulos
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
5
PDF
GLP ‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Type 1 Diabetes: A Propensity‐Matched Real‐World Analysis
2026
·
Anastasios Tentolouris
, Charalampos Filippatos
, et al.
·
Diabetes Obesity and Metabolism
·
4
Real-World Experience with Approved CAR T-Cell Therapies Ciltacabtagene Autoleucel and Idecabtagene Vicleucel in 1272 Relapsed/Refractory Multiple Myeloma Patients
2026
·
Charalampos Filippatos
, Ioannis Ntanasis-Stathopoulos
, et al.
·
Cancers
·
4
PDF
Validation of the new IMS/IMWG consensus genomic staging (CGS) of high‐risk multiple myeloma (HRMM) in a contemporary cohort of 1209 patients
2025
·
Efstathios Kastritis
, Charalampos Filippatos
, et al.
·
HemaSphere
·
4
Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice
2025
·
Ioannis Ntanasis-Stathopoulos
, Vassilis Koutoulidis
, et al.
·
Journal of Clinical Medicine
·
4
Sotatercept as an Add-On to Background Therapy in Idiopathic Pulmonary Arterial Hypertension: Insights from a Real-World Cohort
2026
·
Charalampos Filippatos
, Ioannis Boutsikos
, et al.
·
Pharmaceuticals
·
3
Real‐World Outcomes of Mycosis Fungoides and Site‐Specific Nodal Involvement: A Registry‐Based Study of 25 467 Patients
2026
·
Charalampos Filippatos
, Alexandros Briasoulis
, et al.
·
American Journal of Hematology
·
3
A systematic review of the efficacy of cancer vaccines in advanced breast cancer
2025
·
Anna Charalampopoulou
, Charalampos Filippatos
, et al.
·
Breast Cancer
·
3
PDF
Pomalidomide, Cyclophosphamide, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Experience
2025
·
Ioannis Ntanasis-Stathopoulos
, Panagiotis Malandrakis
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
3
PDF
Evaluating Minimal Residual Disease Negativity As a Surrogate Endpoint for Treatment Efficacy in Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials
2024
·
Ioannis Ntanasis-Stathopoulos
, Charalampos Filippatos
, et al.
·
Blood
·
3
PDF
Real-world cardiovascular safety profile of bexarotene for the treatment of mycosis fungoides
2026
·
Charalampos Filippatos
, Despina Fotiou
, et al.
·
Clinical and Experimental Medicine
·
2
PDF
Cardiovascular Safety of Carfilzomib in Patients with Multiple Myeloma
2025
·
Anastasios Tentolouris
, Ioannis Ntanasis-Stathopoulos
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
Neoadjuvant Imatinib in Recurrent/Metastatic Gastrointestinal Stromal Tumors: A Systematic Review and Meta-analysis of Proportions
2025
·
Niki Stavrou
, Nikolaos Memos
, et al.
·
Journal of Gastrointestinal Cancer
·
2
Real-World Experience With Mogamulizumab for Mycosis Fungoides and Sézary Syndrome
2026
·
Charalampos Filippatos
, Maria Gavriatopoulou
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Progression of Disease Within 24 Months (POD24) is an Independent Prognostic Factor for Survival in Waldenström Macroglobulinemia
2026
·
Maria Gavriatopoulou
, Ioannis Ntanasis-Stathopoulos
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Show more works
View as search
Works count:
57
Citation count:
192
H-index:
7
I10-index:
5
Year
Topic
Type